Primary Record
BMS 493
- In stock
- 8,417 g
- Purity
- 99.1 %
- CAS
- 215030-90-3
Compound Identifiers & Properties
- CAS
- 215030-90-3
- PubChem CID
- 9909190
- SMILES
- CC1(CC=C(C2=C1C=CC(=C2)/C=C/C3=CC=C(C=C3)C(=O)O)C#CC4=CC=CC=C4)C
- Canonical SMILES
- CC1(C)CC=C(C#Cc2ccccc2)c2cc(/C=C/c3ccc(C(=O)O)cc3)ccc21
Names & Synonyms
- BMS 493
- BMS493
- Epofolate
- 215030-90-3
- BMS-493
- RefChem:120782
- Epothilone folate conjugate
- D0N2GC
- CHEMBL472172
- 97% mix TBC as stabilizer
- CHEBI:132086
- GTPL2641
- orb1707523
- SCHEMBL3690042
- SCHEMBL29374587
- YCADIXLLWMXYKW-CMDGGOBGSA-N
- DTXSID801034187
- BMS-204493
- C29H24O2
- BDBM50447840
- BMS204493
- EX-A14139
- MFCD17215944
- ZINC34023910
- AKOS024457650
- BMS 204493
- BMS-753493
- BMS204,493
- CID9909190
- BMS 204,493
- BMS-204,493
- BMS-204493?
- BMS204, 493
- CID:9909190
- NCGC00387103-01
- MS-26920
- SID:329585600
- BMS 493, >=98% (HPLC)
- DB-194252
- HY-108529
- RT-011577
- B7415
- CS-0029097
- J3.040.729F
- 4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoic acid
- 4-{(E)-2-[5,5-dimethyl-8-(phenylethynyl)-5,6-dihydronaphthalen-2-yl]ethenyl}benzoic acid
- G13927
- C542472
- A1244649
- BMS-748285 folate conjugate, Bristol-Myers Squibb
- Q27075350
- 4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(phenylethynyl)-2-naphthalenyl]ethenyl]-benzoic acid
- 4-[(E)-2-[5,5-dimethyl-8-(2-phenylethynyl)-5,6-dihydronaphthalen-2-yl]ethenyl]benzoic acid
- 4-[(E)-2-[5,5-dimethyl-8-(2-phenylethynyl)-6H-naphthalen-2-yl]ethenyl]benzoic Acid
- (E)-4-(2-(5,5-Dimethyl-8-(phenylethynyl)-5,6-dihydronaphthalen-2-yl)vinyl)benzoic acid
- 4-{(E)-2-[5,5-Dimethyl-8-(phenylethynyl)-5,6-dihydro-2-napht
- (E)-4-[2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl]ethen-1-yl]benzoic acid
- Targeted epothilone-folate conjugate (Endocyte technology, cancer), BMS
- (E)-4-(2-(5,5-Dimethyl-8-(phenylethynyl)-5,6-dihydronaphthalen-2-yl)vinyl)benzoicacid
- 4-(1E)-2-5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenylethenylbenzoic Acid
- 4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid
- 4-[(E)-2-[5,5-dimethyl-8-(2-phenylethynyl)-6H-naphthalen-2-yl]vinyl]benzoic acid
- 4-[2-[5,5-Dimethyl-8-(phenylethynyl)-5,6-dihydronaphthalene-2-yl]vinyl]benzoic acid
- 4-{(E)-2-[5,5-Dimethyl-8-(phenylethynyl)-5,6-dihydro-2-naphthalen yl]vinyl}benzoic acid
- 4-{2-[5,5-dimethyl-8-(2-phenylethynyl)-5,6-dihydronaphthalen-2-yl]ethenyl}benzoic acid
- Targeted epothilone-folate conjugate (Endocyte technology, cancer), Bristol-Myers Squibb
- 4-((1E)-2-(1,2-dihydro-1,1-dimethyl-4-(2-phenylethynyl)naphthalen-6-yl)vinyl)benzoic acid
- 4-((E)-2-(5,5-dimethyl-8-(2-phenylethynyl)-5,6-dihydronaphthalen-2-yl)ethenyl)benzoic acid
- 958646-17-8
- EQO